https://www.medicines.ie/medicines/kisunla-350-mg-concentrate-for-solution-for-infusion-36708/patient-info
Kisunla 350 mg concentrate for solution for infusion | PIL | medicines.ie
Patient Information Leaflets | Eli Lilly and Company (Ireland) Limited
kisunlamgconcentratesolutioninfusion
https://alzheimersweekly.com/kisunla-for-alzheimers-now-40-safer/
Kisunla for Alzheimer's Now 40% Safer
Jul 27, 2025 - FDA approves a newly recommended dosing schedule for Kisunla (Donanemab). It's significantly safer due to lowered ARIA-E rates, which has been the main problem...
kisunlaalzheimersafer